Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space
MWN-AI** Summary
Windtree Therapeutics, Inc. (OTCID: WINT), based in Warrington, Pennsylvania, has announced a significant strategic move by signing a letter of intent to acquire CommLoan, Inc., a revenue-generating company in the fintech sector. This acquisition aligns with Windtree's goal to diversify its business portfolio and enhance profitability through new revenue streams.
CommLoan, founded in 2014 and headquartered in Scottsdale, Arizona, is a technology-driven firm that innovates the commercial real estate lending process. Its proprietary platform, CUPID™, simplifies loan origination by connecting borrowers with a variety of active lenders nationwide, allowing for efficient comparisons of rates and loan terms across multiple property types. This technological edge not only enhances efficiency but also establishes a competitive moat in the thriving fintech landscape.
Jed Latkin, CEO of Windtree, expressed enthusiasm regarding the acquisition, highlighting CommLoan’s robust proprietary database that could take years for competitors to replicate. He believes that CommLoan will be instrumental in Windtree's growth strategy, particularly in leveraging software and AI to advance lending processes. CommLoan's CEO and founder, Mitch Ginsberg, echoed this sentiment, stating that joining Windtree will accelerate their mission while allowing them to maintain control over their vision and expansion trajectory.
Additionally, as part of this transition, Windtree has provided bridge financing to CommLoan, which will retain its key employees and operate as a subsidiary. This merger is poised to facilitate rapid growth for both companies in the evolving financial technology landscape, marking an exciting new chapter for both Windtree and CommLoan.
For further insights, stakeholders can visit CommLoan's website or review Windtree's periodic reports available on the SEC’s platform.
MWN-AI** Analysis
Windtree Therapeutics, Inc. (OTCID: WINT) recently announced its intent to acquire CommLoan, Inc., a move that reflects a strategic pivot towards diversifying revenue streams within the burgeoning fintech sector. This acquisition is significant for several reasons, particularly in the context of rapidly evolving market dynamics in commercial real estate financing.
CommLoan’s technology platform, CUPID™, addresses one of the most pressing challenges in the commercial mortgage sector: the cumbersome loan origination process. Their proprietary database not only provides a competitive edge but also positions CommLoan as a leader in leveraging AI and software solutions in finance. Given that CommLoan’s platform allows borrowers to efficiently connect with a multitude of lenders, it can expect traction as more businesses turn to technology for improved operational efficiency—especially in a post-pandemic environment where digital transformation has accelerated.
For investors, this acquisition represents an opportunity to engage with a company that is proactively repositioning itself to become a revenue-generating entity. CEO Jed Latkin's focus on finding strategic partnerships to enhance growth is encouraging, suggesting a methodical approach that may resonate well with risk-averse investors. The retained key personnel from CommLoan, along with the initial financial support from Windtree, further fortifies this partnership, reducing integration risk and promoting business continuity.
However, potential investors should remain cautious. The complexities of integrating a fintech startup with a biotech company can present risks, especially in maintaining focus and operational efficiency. Moreover, the company must navigate the broader economic conditions affecting lending and real estate markets.
In conclusion, while Windtree's acquisition of CommLoan appears promising, investors should monitor the execution of this strategy and its impact on revenue generation, as well as any broader market fluctuations that could influence the success of this and future initiatives.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions
CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated
CommLoan has streamlined the process of obtaining commercial real estate financing
WARRINGTON, Pa., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent to acquire CommLoan, Inc., a commercial tech finance company.
CommLoan will retain key employees and become a subsidiary of Windtree. Windtree has provided bridge financing to CommLoan during this transition period.
“Windtree is pleased to add a revenue generating fintech business as our subsidiary,” said Jed Latkin, Chief Executive Officer of Windtree. “We have spent several quarters trying to find the right business to spearhead our growth initiatives and we are very enthusiastic that CommLoan provides us with a unique advantage to seize on the growing trend in using software and AI to streamline the lending process. CommLoan has put together a massive proprietary database that would take years to replicate and creates a massive moat between them and the other companies trying to compete in this space.”
"We’ve spent years developing technology that revolutionizes how commercial real estate loans are originated. Joining forces with Windtree positions us to accelerate that mission while maintaining control of our long-term direction. This marks an exciting new chapter for CommLoan as we prepare for rapid expansion and the path ahead," said Mitch Ginsberg, CEO and Founder of CommLoan.
About Windtree Therapeutics, Inc.
Windtree Therapeutics, Inc. is a diversified company with several divisions and focused on becoming a revenue generating company with future profitability.
About CommLoan, Inc.
CommLoan is a commercial real estate lending technology company operating the first true commercial mortgage lending marketplace. Through its proprietary platform, CUPID™, CommLoan connects borrowers and originators with hundreds of active lenders nationwide, allowing users to efficiently compare rates, terms, and loan structures across property types, including multifamily, retail, office, industrial, healthcare, and SBA financing. Established in 2014 and headquartered in Scottsdale, Arizona, CommLoan is redefining commercial mortgage lending through technology, transparency, and data-driven efficiency. For more information, visit www.commloan.com.
Forward Looking Statements
The Company may, in some cases, use terms such as “predicts,” “believes,” “potential,” “proposed,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. Such statements are based on information available to the Company as of the date of this press release and are subject to numerous important factors, risks, and uncertainties that may cause actual events or results to differ materially from the Company’s current expectations. Examples of such risks and uncertainties include, among other things: risks related to the Company’s ability to begin its environmental services business and manage costs and execute on its operational and budget plans. These and other risks are described in the Company’s periodic reports, including its Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, filed with or furnished to the Securities and Exchange Commission and available at www.sec.gov. Any forward-looking statements that the Company makes in this press release speak only as of the date of this press release. The Company assumes no obligation to update forward-looking statements whether as a result of new information, future events, or otherwise, after the date of this press release.
Contact Information:
Eric Curtis
[email protected]
FAQ**
How does Windtree Therapeutics Inc. WINT plan to integrate CommLoan's technology and proprietary database into its existing operations to enhance revenue generation and streamline processes?
What specific growth initiatives and strategies does Windtree Therapeutics Inc. WINT envision for CommLoan in the next 1-3 years following the acquisition?
Can Windtree Therapeutics Inc. WINT outline the key performance indicators it will use to measure the success of CommLoan as a subsidiary, particularly in terms of revenue and profitability?
What potential challenges does Windtree Therapeutics Inc. WINT anticipate during the transition of CommLoan into its operations, and how does it plan to address them to ensure a smooth integration?
**MWN-AI FAQ is based on asking OpenAI questions about Windtree Therapeutics Inc. (NASDAQ: WINT).
NASDAQ: WINT
WINT Trading
-12.12% G/L:
$0.116 Last:
1,921,610 Volume:
$0.132 Open:
